53.
Hatzivassiliou G., Haling J.R., Chen H., Song K., Price S., Heald R., Hewitt J.F.M., Zak M., Peck A., Orr C., Merchant M., Hoeflich K.P., Chan J., Luoh S.-M., Anderson D.J., Ludlam M.J.C., Wiesmann C., Ultsch M., Friedman L.S., Malek S., Belvin M. (2013) Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. Nature 501: 232-236.